← The Wire
TOVXNYSE
Theriva Biologics, Inc.
Pharmaceutical Preparations · NV · CIK 894158
Developing oncolytic adenovirus therapeutics to treat cancer and related diseases
$14M
Market cap
$0.26
Last close
+4.1%
1D
+2.8%
5D
1.2M
Volume
Price · last 39 sessions-31.5%
May 4L $0.24 · H $0.38Jun 29
572
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
8-K/ACompany UpdateSep 6, 20228-K/AAcquisition / DispositionMay 6, 20228-K/AEquity IssuanceFeb 12, 20218-K/ABylaw Amendment · Shareholder VoteFeb 1, 20218-K/ARestatementMay 30, 20128-K/ACompany UpdateFeb 3, 20128-K/AExecutive ChangeMar 31, 20108-K/AMaterial Agreement · Acquisition / DispositionOct 19, 20098-K/AAcquisition / DispositionSep 24, 20098-K/AAuditor Change · Change of ControlNov 7, 20068-K/ACompany UpdateDec 21, 2001
Similar companies
Comparable business profile · signals at a glance